Back to search

Article

Endemic Seasonal Coronavirus Neutralisation and COVID-19 severity

2021-10-01

Abstract excerpt

The virus SARS-CoV-2, responsible for the global COVID-19 pandemic, spread rapidly around the world causing high morbidity and mortality because humans have no pre-existing immunity. However, there are four known, endemic seasonal coronaviruses in humans (HCoVs) and whether antibodies for these HCoVs play a role in severity of COVID-19 disease has generated a lot of interest. Of these seasonal viruses NL63 is of p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cde63bc3-3523-5bc9-8736-641bea098c40
DOI
10.1101/2021.09.29.21264328
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endemic Seasonal Coronavirus Neutralisation and COVID-19 severityDOI 10.1101/2021.09.29.21264328
Neutralisation hierarchy of SARS-CoV-2 Variants of Concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholdsSemantic proximity
Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 diseaseSemantic proximity
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.Semantic proximity
Neutralising antibodies predict protection from severe COVID-19Semantic proximity
Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infectionSemantic proximity
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New ZealandSemantic proximity
The effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household membersSemantic proximity
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronavirusesSemantic proximity
Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationSemantic proximity
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in ScotlandSemantic proximity
Distinct antibody responses to endemic coronaviruses pre- and post-SARS-CoV-2 infection in Kenyan infants and mothersSemantic proximity
Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2Semantic proximity
Select a neighboring publication to make it the new centre.